Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Website Related Posts Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 RHI: Acqn of royalty over Sandstone Gold Project tenements April 28, 2025 Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025
Silver Crown Royalties Announces Closing of Final Tranche of its Non-Brokered Private Placement April 28, 2025